Page 3 - Core Lab News Today

Operator: Good morning and welcome to the Core Lab Quarter One 2024 earnings call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.

Group sales grew by 2%1 at constant exchange rates , driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there...

FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAR-OVER-YEARFIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR...

Core Laboratories Inc. reported first quarter 2024 ...

Core Laboratories Inc. ...

/PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Cores...

Patients having heart bypass surgery can be spared an unpleasant and invasive form of diagnosis following a successful clinical trial led by Irish surgeons, a new study reveals today.

The research found that the approach was 99.1 per cent feasible, with the cardiac CT scanning offering good diagnostic accuracy. The study involved 114 patients who had severe blockages in multiple vessels, limiting blood flow to their heart

The study introduced the concept of using high-resolution cardiovascular imagery and AI-powered blood flow analysis to guide surgical decisions, potentially reducing the need for invasive procedures and enhancing patient care.

A trial co-ordinated by researchers at the University of Galway used high resolution CT scans to identify blockages in coronary arteries.